---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-006398"
form_type: "8-K"
ticker: "ABEO"
cik: "0000318306"
company_name: "ABEONA THERAPEUTICS INC."
filed_at: "2022-03-09T23:59:59+00:00"
generated_at: "2026-06-27T00:31:53.736135+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Abeona Therapeutics CFO Edward Carr resigns; Joseph Vazzano appointed new CFO

## Summary
- Edward Carr resigns effective March 31, 2022; no disagreement with company.
- Joseph Vazzano appointed CFO effective March 14, 2022; previously CFO of Avenue Therapeutics (ATXI).
- Vazzano receives $360k base salary, 40% target bonus, 200k restricted shares; potential increase to $400k salary.
- Vazzano to become principal financial and accounting officer on March 31, 2022.

## SEC filing metadata
- accession: 0001493152-22-006398
- form_type: 8-K
- ticker: ABEO
- cik: 0000318306
- company_name: ABEONA THERAPEUTICS INC.
- filed_at: 2022-03-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/318306/000149315222006398/0001493152-22-006398-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/318306/000149315222006398/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-006398
- JSON: https://secwatch.observer/filing/0001493152-22-006398.json
- Plain text: https://secwatch.observer/filing/0001493152-22-006398.txt

## Key facts
- Executive change
  Edward Carr resigned as Chief Financial Officer at ABEONA THERAPEUTICS INC..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On March 3, 2022, Edward Carr, Chief Financial Officer and Chief Accounting Officer of Abeona Therapeutics Inc. (the “Company”), notified the Company of his resignation effective March 31, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/318306/000149315222006398/0001493152-22-006398-index.htm
- Executive change
  Joseph Vazzano was appointed as Chief Financial Officer at ABEONA THERAPEUTICS INC..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: Also on March 3, 2022, the Board appointed Joseph Vazzano as Chief Financial Officer effective March 14, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/318306/000149315222006398/0001493152-22-006398-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.